New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression

Schizophrenia and depression are heterogeneous disorders. The complex pathomechanism of the diseases imply that medication responses vary across patients. Many psychotropic drugs are available but achieving optimal therapeutic effect can be challenging. The evidence correlates well with clinical obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Orzelska-Górka, Jolanta, Mikulska, Joanna, Wiszniewska, Anna, Biała, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500595/
https://www.ncbi.nlm.nih.gov/pubmed/36142523
http://dx.doi.org/10.3390/ijms231810624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500595/
https://www.ncbi.nlm.nih.gov/pubmed/36142523
http://dx.doi.org/10.3390/ijms231810624

Ejemplares similares